FDA Inspection 1317040 — Hemagen Diagnostics Inc
The FDA completed an inspection of Hemagen Diagnostics Inc on May 14, 2026 in Baltimore, MD. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Devices.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- May 14, 2026
- Fiscal Year
- 2026
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Baltimore, MD (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 23044 | ISO 13485:2016 Clause 4.2.5 | Procedures for control of records not documented |
| 23142 | ISO 13485:2016 Clause 7.4.1 | Supplier performance not monitored |
| 23255 | ISO 13485:2016 Clause 8.5.2 | Corrective action not taken |
| 23258 | ISO 13485:2016 Clause 8.5.2 | Corrective action procedures not documented |
Need the full FDA record for Hemagen Diagnostics Inc? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.